Serizawa, Kenichi <br/><br/>
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats.  [electronic resource] 

 -  European journal of pharmacology  Nov 2015 
 - 10-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2015.09.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Pressure--drug effects<br/>Body Weight--drug effects<br/>Creatinine--blood<br/>Disease Models, Animal<br/>Endothelium, Vascular--drug effects<br/>Erythropoietin--pharmacology<br/>Femoral Artery--diagnostic imaging<br/>Heart Rate--drug effects<br/>Hemoglobins--metabolism<br/>Kidney Function Tests<br/>Male<br/>NADPH Oxidase 4<br/>NADPH Oxidases--biosynthesis<br/>Nephrectomy<br/>Nitric Oxide Synthase Type III--metabolism<br/>Nitroglycerin--pharmacology<br/>Polyethylene Glycols--pharmacology<br/>Proteinuria--urine<br/>Rats<br/>Renal Insufficiency, Chronic--blood<br/>Tyrosine--analogs & derivatives<br/>Ultrasonography<br/>Vasodilation--drug effects